Price
Target price
€32.21
€32.21
0.480%
0.15
0.480%
€124.35
09.01.26 / Tradegate
WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Corcept Therapeutics Inc. Stock
Corcept Therapeutics Inc. gained 0.480% compared to yesterday.
Corcept Therapeutics Inc. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
Based on the current price of 32.21 € the target price of 124 € shows a potential of 284.97% for Corcept Therapeutics Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Corcept Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | 0.480% | -1.136% | -54.964% | -35.709% | -52.896% | 66.159% | 46.409% |
| Rockwell Medical Inc. | -0.960% | 13.833% | 4.222% | -59.381% | 22.247% | -21.981% | -91.258% |
| Pacira Pharmaceuticals | - | 7.767% | 4.717% | 25.424% | 2.778% | -34.706% | -60.357% |
| Twist Bioscience Corp | 3.320% | 9.837% | 11.778% | -30.567% | 9.048% | 32.187% | -77.832% |
Comments
Corcept Therapeutics (NASDAQ:CORT) had its price target lowered by analysts at HC Wainwright from $145.00 to $90.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (NASDAQ:CORT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $145.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat